US study finds only 35% of newly diagnosed patients on DMT in follow-up years on: August 14, 2020, 08:41:42 pm #1 From Multiple Sclerosis News Today (August 14, 2020)--"35% of Newly Diagnosed Patients Given DMT in Follow-Up Years, US Study Finds": 35% of Newer Patients Given DMT in Follow-up Years, US Study Finds A study looking at insured patients in US diagnosed from 2014-19 with MS found a "gap"of nearly two-thirds not treated within guidelines. Multiple Sclerosis News Today · bit.ly Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
